Alpelisib (Piqray)

alpelisib · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alpelisib (Piqray), covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: 24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs [Phase 2]